Navigation Links
Cellceutix Poster Presentation on its p53 Cancer Breakthrough Attracts Wide Interest at 102nd AACR Meeting
Date:4/11/2011

ccess in humans, though they may form the basis for beginning Phase 1 trials.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by Cellceutix Corporation are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.


'/>"/>
SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
2. Cellceutix Discovers Drug Activates Guardian Angel p53 in Fight Against Leukemia
3. Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company
4. Cellceutix Reports Production of Its Anti-Cancer Drug Kevetrin™ Has Begun
5. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium
7. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
8. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting
10. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
11. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... , Sept. 20, 2014 /CNW/ - The issue: Mylan Pharmaceuticals ... all lots of its Mylan-Nitro Spray 0.4 mg/metered dose due ... of the pump component. A missing "dip ... nitroglycerin to the patient. This defect may lead patients to ... are unable to access it. Not receiving nitroglycerin could place ...
(Date:9/19/2014)... 2014 Medical science liaisons (MSLs) play ... opinion leaders (KOLs) who can provide essential insights ... nature of the MSL function, the changing regulatory ... landscape for creating and maintaining KOL and physician ... oversight responsibility for the MSL function is increasingly ...
(Date:9/19/2014)... NEW YORK , Sept. 19, 2014 ... claims against the board of directors of PDL BioPharma, ... ) concerning whether the board has breached its fiduciary ... On September 16, 2014, the Company disclosed: ... its independent registered accounting firm, Ernst & Young LLP ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
... 7, 2011 Adeona Pharmaceuticals, Inc. (AMEX: AEN ... system diseases, announced today that it has executed an agreement ... at approximately $2.0725 per share to a new institutional investor ... proceeds. The investor will also receive warrants to purchase approximately ...
... Graymark Healthcare Inc. (NASDAQ: GRMH ), ... and an innovator in comprehensive care for obstructive sleep ... resupply shipments in the first quarter of 2011.  Resupply ... in what is typically the slowest quarter of the ...
Cached Medicine Technology:Adeona to Raise $3.5 Million in Registered Direct Offering 2Adeona to Raise $3.5 Million in Registered Direct Offering 3Graymark Resupply Orders Reach Record Levels in Q1 2011, Up 107% Year-Over-Year 2Graymark Resupply Orders Reach Record Levels in Q1 2011, Up 107% Year-Over-Year 3
(Date:9/20/2014)... York, NY (PRWEB) September 20, 2014 ... Ariana Grande concert tickets . This popular ticket exchange ... savings. , The 2015 schedule of tours is ... music have already announced their plans to hit the road, ... Boca Raton, Fla., announced the “Honeymoon Tour,” which will take ...
(Date:9/20/2014)... New York, NY (PRWEB) September 20, 2014 ... Ariana Grande concert tickets. This popular ticket ... added savings. , Ariana Grande is nearing that next step ... is already considered a superstar in the music and entertainment ... who recently released her second straight No. 1 album, will ...
(Date:9/20/2014)... Loma Linda, CA (PRWEB) September 20, 2014 ... Center will receive a $250,000 pediatric cancer research grant ... event at Loma Linda University Children’s Hospital located on ... support the work of Dr. Kimberley Payne, Associate Professor ... Dr. Payne’s work focuses on leukemia in children. ...
(Date:9/20/2014)... September 20, 2014 As testosterone ... in federal court, Bernstein Liebhard LLP notes that ... (FDA) have voted overwhelmingly to recommend that prescription ... be subjected to further study in order to ... published on September 18th by Bloomberg.com, the panel ...
(Date:9/20/2014)... The print component of “Work-Life Balance” is ... Herald, with a circulation of approximately 97,000 copies ... component is distributed nationally through a vast social ... news sites and partner outlets. To explore the ... . , The publication features an exclusive Mediaplanet ...
Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 3Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2
... , WASHINGTON, June 4 The U.S. Agency ... and expand children,s immunization programs in developing countries. , ... to global health and the new global health initiative, a ... May. , , The grant was announced by Deputy ...
... Celebrity volunteers who led more than one million people in March for ... March of Dimes raise urgently needed funds for programs that help moms ... had a premature child, I know firsthand the toll that premature birth ... in supporting the March of Dimes," says Sherri Shepherd ...
... , Fruit2O(R) Essentials(TM) Offers Nutritional Benefits and Flavor of Fruit ... 4 From the creators of Fruit2O(R), the original fruit ... - Fruit2O(R) Essentials(TM) - providing nutrients found in two servings ... , , Studies have shown that 80 percent of ...
... , SAN DIEGO, June 4 Last night, the ... Highmark Blue Shield, Keystone Mercy Health Plan, Group Health ... Plan: four health plans with innovative programs designed to ... country. They carry on a tradition among health plans ...
... , LAWRENCE, Mass., June 4 NxStage Medical, Inc. (Nasdaq: ... products, today announced that Jeffrey H. Burbank, Chief Executive Officer, ... on Tuesday, June 9, 2009 at The Four Seasons Hotel ... is scheduled for Tuesday, June 9th at 4:30 p.m. (CST). ...
... protein that could lead to treatment or prevention , THURSDAY, ... that plays a key role in cell death in Huntingdon,s ... loss of intellectual functioning. , The discovery raises hope that ... according to a study in the June 5 issue of ...
Cached Medicine News:Health News:U.S. Contributes $75 Million for Childhood Immunization 2Health News:Celebrities Lead One Million Walkers and Urge Public to Support March for Babies(R) 2Health News:Celebrities Lead One Million Walkers and Urge Public to Support March for Babies(R) 3Health News:Fruit2O(R) Introduces New 'Essentials' Line 2Health News:Fruit2O(R) Introduces New 'Essentials' Line 3Health News:AHIP Foundation Announces 2009 Community Leadership Awards 2Health News:NxStage to Present at the William Blair Growth Stock Conference 2Health News:Discovery Sheds Light on Huntington's Disease 2Health News:Discovery Sheds Light on Huntington's Disease 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: